2026年全球衣殼偏好篩檢平台市場報告

近年來，衣殼嗜性篩檢平台的市場規模迅速擴張。預計該市場規模將從2025年的7.4億美元成長到2026年的8.5億美元，複合年成長率（CAGR）為14.2%。過去幾年成長要素包括：基因治療研究投入的增加、對病毒載體最佳化需求的成長、流式細胞技術和定序技術的應用、對個人化醫療的日益重視，以及製藥和生物技術領域研發基礎設施的擴建。

預計未來幾年衣殼嗜性篩檢平台市場將快速成長，年複合成長率（CAGR）將達到14.4%，到2030年市場規模將達到14.5億美元。預測期內的成長預計將受到以下因素的推動：人工智慧驅動的衣殼嗜性分析的日益普及、高內涵成像和微流體技術的廣泛應用、對單細胞定序和先進篩檢平台的需求不斷成長、合約研究組織（CRO）的擴張，以及多重檢測和數位PCR技術的日益融合。預測期內的關鍵趨勢包括：高通量篩檢平台的廣泛應用、對次世代定序解決方案的需求不斷成長、流式細胞技術技術的融合發展、檢測試劑盒和試劑產品的擴展，以及對基因治療和疫苗開發應用的日益關注。

預計在預測期內，對標靶基因治療日益成長的需求將推動衣殼嗜性篩檢平台市場的擴張。標靶基因治療是指將治療性遺傳物質遞送至特定細胞或組織，以糾正、修飾或替換導致疾病的缺陷基因。推動此類治療方法需求激增的因素有很多，包括遺傳性疾病和罕見疾病發病率的上升、載體工程技術的進步，以及旨在提高療效並最大限度減少脫靶效應的精準醫療領域投資的增加。衣殼嗜性篩檢平台在基因治療開發中至關重要，它能夠系統地評估和篩選具有最佳組織和細胞特異性的病毒載體。例如，據美國基因與細胞治療協會（一家總部位於美國的基因和細胞治療組織）稱，截至2024年1月，2023年第四季度處於III期臨床試驗階段的基因療法數量成長了10%，這是自2022年第三季度以來的首次以季度為基礎成長。因此，對標靶基因治療日益成長的需求正在推動衣殼嗜性篩檢平台市場的成長。

在衣殼嗜性篩檢平台市場中，領導企業正積極建立策略夥伴關係，以開發創新高通量條碼腺結合病毒(AAV)篩檢解決方案。這些策略合作夥伴關係透過促進先進 AAV篩檢技術的共同開發、拓展產品系列以及加速基因療法的研發和商業化，推動了衣殼嗜性篩檢平台市場的成長。例如，2025 年 8 月，美國生物技術公司 PackGene Biotech Inc. 與澳洲獨立機構兒童醫學研究所 (CMRI) 達成策略性授權協議，共同開發條碼高通量腺結合病毒(AAV) 衣殼篩檢盒。這些試劑盒將使研究人員能夠利用條碼系統和次世代定序技術，快速、同時評估多種腺結合病毒衣殼變異。此次合作旨在透過簡化衣殼篩選流程和提升先進篩檢工具的可及性，加速基因療法的研發進程。

目錄

第1章：執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球衣殼偏好篩檢平台市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 清單：主要原料、資源和供應商
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章：全球市場趨勢與策略

• 關鍵科技與未來趨勢
  • 生物技術、基因組學和精準醫療
  • 人工智慧和自主智慧
  • 數位化、雲端運算、巨量資料、網路安全
  • 工業4.0和智慧製造
  • 永續性、氣候技術、循環經濟
• 主要趨勢
  • 擴大高通量篩檢平台的應用
  • 對次世代定序方案的需求日益成長
  • 流式細胞技術技術整合的進展
  • 擴大檢測試劑盒和試劑產品範圍
  • 人們對將其應用於基因治療和疫苗研發越來越感興趣。

第5章 終端用戶產業市場分析

• 製藥和生物技術公司
• 學術研究機構
• 受託研究機構
• 基因治療開發公司
• 疫苗研發公司

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球衣殼偏好篩檢平台市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 全球衣殼偏好篩檢平台市場：規模、對比及成長率分析
• 全球衣殼偏好篩檢平台市場表現：規模與成長，2020-2025年
• 全球衣殼偏好篩檢平台市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

• 透過技術
• 高通量篩檢、次世代定序、流式細胞技術和其他技術
• 依產品類型
• 檢測試劑盒、試劑、儀器、軟體及服務
• 透過使用
• 基因療法、疫苗研發、藥物發現等應用的發展
• 最終用戶
• 製藥和生物技術公司、學術和研究機構、受託研究機構以及其他最終用戶
• 細分（按類型）：高通量篩檢
• 基於細胞的篩檢、生化篩檢、高內涵篩檢、自動化篩檢、無標定篩檢
• 亞片段化（按類型）：次世代定序
• 短讀長定序、長讀長定序、標靶定序、全基因組定序、單細胞定序
• 細分：依類型：流式細胞技術
• 常規流式細胞技術、頻譜流式細胞技術、成像流式細胞技術、細胞分選、質譜流式細胞儀
• 細分：依類型：其他技術
• 基於微流體的篩檢、高內涵成像、質譜分析、聚合酵素鏈鎖反應與數位聚合酵素鏈鎖反應、免疫檢測平台

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 衣殼偏好篩檢平台市場：競爭格局及市場佔有率，2024年
• 衣殼偏好篩檢平台市場：公司估值矩陣
• 衣殼偏好篩檢平台市場：公司概況
  • Sarepta Therapeutics Inc.
  • Voyager Therapeutics Inc.
  • Bluebird Bio Inc.
  • Sangamo Therapeutics Inc.
  • REGENXBIO Inc.

第37章 其他大型企業和創新企業

• MeiraGTx Holdings plc, Dyno Therapeutics Inc., 4D Molecular Therapeutics Inc., Asklepios BioPharmaceutical Inc., PackGene Biotech Inc., Creative Biolabs Inc., VectorBuilder Inc., uniQure NV, Homology Medicines Inc., Capsida Biotherapeutics Inc., LogicBio Therapeutics Inc., Capsigen Inc., GeneMedi Inc., Spark Therapeutics Inc., Creative Biogene Inc.

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

• 2030年衣殼偏好篩檢平台市場：提供新機會的國家
• 2030年衣殼偏好篩檢平台市場：提供新機會的細分市場
• 2030年衣殼偏好篩檢平台市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第42章附錄

Capsid tropism screening platforms are specialized technologies used to evaluate and identify the specific tissue or cell types that viral capsids can effectively target and enter. These platforms allow researchers to optimize viral vectors for gene therapy by assessing delivery efficiency, specificity, and safety across various biological environments.

The key technologies of capsid tropism screening platforms include high-throughput screening, next-generation sequencing, flow cytometry, and other technologies. High-throughput screening refers to advanced methods for rapid evaluation of capsid variants for tissue targeting efficiency and specificity. Product types include assay kits, reagents, instruments, software, and services. Applications include gene therapy development, vaccine development, drug discovery, and other areas, serving pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, and other end-users.

Tariffs on imported reagents, instruments, and high-throughput screening components are affecting the capsid tropism screening platforms market by increasing procurement and operational costs, particularly impacting assay kits, sequencing instruments, and flow cytometry devices. Regions such as North America, Europe, and Asia-Pacific that rely heavily on imported biotech instruments are most affected. While tariffs raise costs, they also encourage domestic manufacturing, support local biotech innovation, and drive the development of cost-efficient, regionally produced reagents and instruments, fostering long-term resilience and supply chain stability.

The capsid tropism screening platforms market research report is one of a series of new reports from The Business Research Company that provides capsid tropism screening platforms market statistics, including capsid tropism screening platforms industry global market size, regional shares, competitors with a capsid tropism screening platforms market share, detailed capsid tropism screening platforms market segments, market trends and opportunities, and any further data you may need to thrive in the capsid tropism screening platforms industry. This capsid tropism screening platforms market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The capsid tropism screening platforms market size has grown rapidly in recent years. It will grow from $0.74 billion in 2025 to $0.85 billion in 2026 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to increasing investment in gene therapy research, growing demand for viral vector optimization, adoption of flow cytometry and sequencing technologies, rising focus on personalized medicine, expansion of pharmaceutical and biotech R&D infrastructure.

The capsid tropism screening platforms market size is expected to see rapid growth in the next few years. It will grow to $1.45 billion in 2030 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to growing use of AI-driven capsid tropism analysis, increasing deployment of high-content imaging and microfluidics, rising demand for single-cell sequencing and advanced screening platforms, expansion of contract research organizations (CROs), increasing integration of multiplex assay and digital PCR technologies. Major trends in the forecast period include increasing adoption of high-throughput screening platforms, rising demand for next-generation sequencing solutions, growing integration of flow cytometry technologies, expansion of assay kits and reagent offerings, rising focus on gene therapy and vaccine development applications.

The growing demand for targeted gene therapies is projected to drive the expansion of the capsid tropism screening platforms market during the forecast period. Targeted gene therapies involve delivering therapeutic genetic material to specific cells or tissues to correct, modify, or replace defective genes responsible for disease. The surge in demand for these therapies is influenced by several factors, including the rising incidence of genetic and rare diseases, advancements in vector engineering technologies, and increased investment in precision medicine approaches designed to enhance treatment effectiveness while minimizing off-target effects. Capsid tropism screening platforms are vital in gene therapy development, enabling systematic evaluation and selection of viral vectors with optimal tissue and cell specificity. For instance, in January 2024, according to the American Society of Gene & Cell Therapy, a US-based gene and cell therapy organization, the number of gene therapies in Phase III clinical trials rose by 10% in Q4 2023, marking the first quarterly increase since Q3 2022. Therefore, the increasing demand for targeted gene therapies is driving the growth of the capsid tropism screening platforms market.

Key companies operating in the capsid tropism screening platforms market are forming strategic partnerships to develop innovative high-throughput and barcoded adeno-associated virus screening solutions. Strategic partnerships propel the growth of the capsid tropism screening platforms market by enabling collaborative development of advanced adeno-associated virus screening technologies, expanding product portfolios, and accelerating gene therapy research and commercialization. For example, in August 2025, PackGene Biotech Inc., a US-based biotechnology company, entered a strategic licensing agreement with the Children's Medical Research Institute (CMRI), an Australia-based independent organization, to commercialize barcoded high-throughput adeno-associated virus capsid screening kits. These kits allow researchers to rapidly evaluate multiple adeno-associated virus capsid variants simultaneously using a barcode system and next-generation sequencing. The collaboration aims to accelerate gene therapy development by streamlining capsid selection and improving access to advanced screening tools.

In April 2023, Ginkgo Bioworks Holdings Inc., a US-based synthetic biology platform company, acquired adeno-associated virus capsid discovery and engineering platform assets from StrideBio for an undisclosed amount. Through this acquisition, Ginkgo Bioworks aims to advance its technological capabilities in viral vector design and capsid tropism screening, reinforcing its position in the gene therapy market. StrideBio Inc. is a US-based provider of advanced adeno-associated virus capsid discovery and engineering technologies that enable optimized tissue-specific delivery for gene therapies.

Major companies operating in the capsid tropism screening platforms market are Sarepta Therapeutics Inc., Voyager Therapeutics Inc., Bluebird Bio Inc., Sangamo Therapeutics Inc., REGENXBIO Inc., MeiraGTx Holdings plc, Dyno Therapeutics Inc., 4D Molecular Therapeutics Inc., Asklepios BioPharmaceutical Inc., PackGene Biotech Inc., Creative Biolabs Inc., VectorBuilder Inc., uniQure N.V., Homology Medicines Inc., Capsida Biotherapeutics Inc., LogicBio Therapeutics Inc., Capsigen Inc., GeneMedi Inc., Spark Therapeutics Inc., Creative Biogene Inc.

North America was the largest region in the capsid tropism screening platforms market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the capsid tropism screening platforms market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the capsid tropism screening platforms market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The capsid tropism screening platforms market consists of revenues earned by entities by providing services such as tissue-specific tropism analysis, high-throughput viral vector profiling, preclinical vector optimization studies, custom assay development for capsid targeting, and cell type-specific transduction efficiency testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The capsid tropism screening platforms market also includes sales of high-throughput screening kits, reporter assays, cell panels, bioinformatics tools, and next-generation sequencing (ngs) kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Capsid Tropism Screening Platforms Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses capsid tropism screening platforms market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for capsid tropism screening platforms ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The capsid tropism screening platforms market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Technology: High-Throughput Screening; Next-Generation Sequencing; Flow Cytometry; Other Technologies
• 2) By Product Type: Assay Kits; Reagents; Instruments; Software; Services
• 3) By Application: Gene Therapy Development; Vaccine Development; Drug Discovery; Other Applications
• 4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations; Other End-Users
• Subsegments:
• 1) By High-Throughput Screening: Cell-Based Screening; Biochemical Screening; High-Content Screening; Automated Screening; Label-Free Screening
• 2) By Next-Generation Sequencing: Short-Read Sequencing; Long-Read Sequencing; Targeted Sequencing; Whole-Genome Sequencing; Single-Cell Sequencing
• 3) By Flow Cytometry: Conventional Flow Cytometry; Spectral Flow Cytometry; Imaging Flow Cytometry; Cell Sorting; Mass Cytometry
• 4) By Other Technologies: Microfluidics-Based Screening; High-Content Imaging; Mass Spectrometry; Polymerase Chain Reaction And Digital Polymerase Chain Reaction; Immunoassay-Based Platforms
• Companies Mentioned: Sarepta Therapeutics Inc.; Voyager Therapeutics Inc.; Bluebird Bio Inc.; Sangamo Therapeutics Inc.; REGENXBIO Inc.; MeiraGTx Holdings plc; Dyno Therapeutics Inc.; 4D Molecular Therapeutics Inc.; Asklepios BioPharmaceutical Inc.; PackGene Biotech Inc.; Creative Biolabs Inc.; VectorBuilder Inc.; uniQure N.V.; Homology Medicines Inc.; Capsida Biotherapeutics Inc.; LogicBio Therapeutics Inc.; Capsigen Inc.; GeneMedi Inc.; Spark Therapeutics Inc.; Creative Biogene Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Capsid Tropism Screening Platforms Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Capsid Tropism Screening Platforms Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Capsid Tropism Screening Platforms Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Capsid Tropism Screening Platforms Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption of High-Throughput Screening Platforms
  • 4.2.2 Rising Demand for Next-Generation Sequencing Solutions
  • 4.2.3 Growing Integration of Flow Cytometry Technologies
  • 4.2.4 Expansion of Assay Kits and Reagent Offerings
  • 4.2.5 Rising Focus on Gene Therapy and Vaccine Development Applications

5. Capsid Tropism Screening Platforms Market Analysis Of End Use Industries

• 5.1 Pharmaceutical And Biotechnology Companies
• 5.2 Academic And Research Institutes
• 5.3 Contract Research Organizations
• 5.4 Gene Therapy Developers
• 5.5 Vaccine Development Companies

6. Capsid Tropism Screening Platforms Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Capsid Tropism Screening Platforms Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Capsid Tropism Screening Platforms PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Capsid Tropism Screening Platforms Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Capsid Tropism Screening Platforms Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Capsid Tropism Screening Platforms Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Capsid Tropism Screening Platforms Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Capsid Tropism Screening Platforms Market Segmentation

• 9.1. Global Capsid Tropism Screening Platforms Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• High-Throughput Screening, Next-Generation Sequencing, Flow Cytometry, Other Technologies
• 9.2. Global Capsid Tropism Screening Platforms Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Assay Kits, Reagents, Instruments, Software, Services
• 9.3. Global Capsid Tropism Screening Platforms Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Gene Therapy Development, Vaccine Development, Drug Discovery, Other Applications
• 9.4. Global Capsid Tropism Screening Platforms Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations, Other End-Users
• 9.5. Global Capsid Tropism Screening Platforms Market, Sub-Segmentation Of High-Throughput Screening, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cell-Based Screening, Biochemical Screening, High-Content Screening, Automated Screening, Label-Free Screening
• 9.6. Global Capsid Tropism Screening Platforms Market, Sub-Segmentation Of Next-Generation Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Short-Read Sequencing, Long-Read Sequencing, Targeted Sequencing, Whole-Genome Sequencing, Single-Cell Sequencing
• 9.7. Global Capsid Tropism Screening Platforms Market, Sub-Segmentation Of Flow Cytometry, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Conventional Flow Cytometry, Spectral Flow Cytometry, Imaging Flow Cytometry, Cell Sorting, Mass Cytometry
• 9.8. Global Capsid Tropism Screening Platforms Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Microfluidics-Based Screening, High-Content Imaging, Mass Spectrometry, Polymerase Chain Reaction And Digital Polymerase Chain Reaction, Immunoassay-Based Platforms

10. Capsid Tropism Screening Platforms Market Regional And Country Analysis

• 10.1. Global Capsid Tropism Screening Platforms Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Capsid Tropism Screening Platforms Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Capsid Tropism Screening Platforms Market

• 11.1. Asia-Pacific Capsid Tropism Screening Platforms Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Capsid Tropism Screening Platforms Market

• 12.1. China Capsid Tropism Screening Platforms Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Capsid Tropism Screening Platforms Market

• 13.1. India Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Capsid Tropism Screening Platforms Market

• 14.1. Japan Capsid Tropism Screening Platforms Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Capsid Tropism Screening Platforms Market

• 15.1. Australia Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Capsid Tropism Screening Platforms Market

• 16.1. Indonesia Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Capsid Tropism Screening Platforms Market

• 17.1. South Korea Capsid Tropism Screening Platforms Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Capsid Tropism Screening Platforms Market

• 18.1. Taiwan Capsid Tropism Screening Platforms Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Capsid Tropism Screening Platforms Market

• 19.1. South East Asia Capsid Tropism Screening Platforms Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Capsid Tropism Screening Platforms Market

• 20.1. Western Europe Capsid Tropism Screening Platforms Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Capsid Tropism Screening Platforms Market

• 21.1. UK Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Capsid Tropism Screening Platforms Market

• 22.1. Germany Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Capsid Tropism Screening Platforms Market

• 23.1. France Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Capsid Tropism Screening Platforms Market

• 24.1. Italy Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Capsid Tropism Screening Platforms Market

• 25.1. Spain Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Capsid Tropism Screening Platforms Market

• 26.1. Eastern Europe Capsid Tropism Screening Platforms Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Capsid Tropism Screening Platforms Market

• 27.1. Russia Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Capsid Tropism Screening Platforms Market

• 28.1. North America Capsid Tropism Screening Platforms Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Capsid Tropism Screening Platforms Market

• 29.1. USA Capsid Tropism Screening Platforms Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Capsid Tropism Screening Platforms Market

• 30.1. Canada Capsid Tropism Screening Platforms Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Capsid Tropism Screening Platforms Market

• 31.1. South America Capsid Tropism Screening Platforms Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Capsid Tropism Screening Platforms Market

• 32.1. Brazil Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Capsid Tropism Screening Platforms Market

• 33.1. Middle East Capsid Tropism Screening Platforms Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Capsid Tropism Screening Platforms Market

• 34.1. Africa Capsid Tropism Screening Platforms Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Capsid Tropism Screening Platforms Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Capsid Tropism Screening Platforms Market Regulatory and Investment Landscape

36. Capsid Tropism Screening Platforms Market Competitive Landscape And Company Profiles

• 36.1. Capsid Tropism Screening Platforms Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Capsid Tropism Screening Platforms Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Capsid Tropism Screening Platforms Market Company Profiles
  • 36.3.1. Sarepta Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Voyager Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Bluebird Bio Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Sangamo Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. REGENXBIO Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Capsid Tropism Screening Platforms Market Other Major And Innovative Companies

• MeiraGTx Holdings plc, Dyno Therapeutics Inc., 4D Molecular Therapeutics Inc., Asklepios BioPharmaceutical Inc., PackGene Biotech Inc., Creative Biolabs Inc., VectorBuilder Inc., uniQure N.V., Homology Medicines Inc., Capsida Biotherapeutics Inc., LogicBio Therapeutics Inc., Capsigen Inc., GeneMedi Inc., Spark Therapeutics Inc., Creative Biogene Inc.

38. Global Capsid Tropism Screening Platforms Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Capsid Tropism Screening Platforms Market

41. Capsid Tropism Screening Platforms Market High Potential Countries, Segments and Strategies

• 41.1 Capsid Tropism Screening Platforms Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Capsid Tropism Screening Platforms Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Capsid Tropism Screening Platforms Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer